博瑞医药终止向特定对象发行股票审核

Core Viewpoint - The company, Borui Biopharmaceutical (Suzhou) Co., Ltd., has decided to terminate its plan for a specific issuance of A-shares for the year 2024 and has withdrawn its application documents [1] Group 1 - The fourth meeting of the fourth board of directors was held to review and approve the resolution to terminate the issuance of A-shares [1] - Related director Yuan Jiandong abstained from voting on the resolution [1] - The company and its sponsor, Guolian Minsheng Securities Co., Ltd., submitted applications to the Shanghai Stock Exchange to withdraw the application documents and revoke the sponsorship work [1] Group 2 - On October 21, the company announced that it had received a decision from the Shanghai Stock Exchange to terminate the review of its specific issuance of shares [1] - The Shanghai Stock Exchange made this decision based on relevant regulations [1]